marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Ovid Therapeutics Financial Ratios 2011-2024 | OVID
Annual Financial Ratios Ovid Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.2 | -2.6 | 1.5 | -2.1 | -2.2 | -1.5 | -2.5 | - | - | - | - | - | - |
P/S |
564.0 | 94.2 | 0.9 | 13.2 | - | - | - | - | - | - | - | - | - |
EPS |
-0.7 | -0.8 | 1.8 | -1.4 | - | -2.1 | -3.4 | -2.3 | -1.4 | - | - | - | - |
EV (Enterprise Value) |
250 M | 120 M | 13.2 M | 127 M | 103 M | 50.9 M | 79.8 M | -48.2 M | 2.31 M | - | - | - | - |
EBITDA per Share |
-0.83 | -0.78 | 1.84 | -1.37 | -1.56 | -2.14 | -3.36 | - | - | - | - | - | - |
EV/EBITDA |
-0.3 | -1.2 | -1.5 | -0.8 | -1.1 | - | - | - | - | - | - | ||
PEG |
0.05 | 0.03 | - | -0.21 | -0.08 | -0.04 | 0.07 | - | - | - | - | - | - |
P/B |
2.5 | 1.1 | 1.0 | 3.8 | 1.9 | 2.0 | 1.9 | - | - | - | - | - | - |
P/CF |
-4.8 | -2.6 | 1.6 | -3.2 | -2.6 | -1.7 | -5.1 | - | - | - | - | - | - |
ROE % |
-59.61 | -40.95 | 68.34 | -185.73 | -86.34 | -133.95 | -77.67 | - | - | - | - | - | - |
ROA % |
-36.34 | -34.89 | 63.14 | -106.73 | -74.79 | -109.09 | -72.44 | - | - | - | - | - | - |
ROCE % |
-67.52 | -42.00 | 69.10 | -151.18 | -87.34 | -136.40 | -77.91 | - | - | - | - | - | - |
Current Ratio |
2.6 | 6.8 | 13.1 | 3.4 | 7.6 | 5.0 | 14.7 | - | - | - | - | - | - |
DSO |
- | - | - | 4.1 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Ovid Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.2 | 0.12 | -0.17 | - | -0.16 | -0.18 | -0.19 | - | -0.17 | -0.21 | -0.23 | - | -0.17 | -0.23 | 2.55 | - | -0.28 | -0.41 | -0.37 | -0.35 | -0.43 | -0.34 | -0.46 | -0.52 | -0.53 | -0.53 | -0.54 | -0.45 | -0.38 | -0.57 | -3.48 | -0.77 | -0.59 | -0.55 | -0.37 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.18 | -0.29 | -0.24 | - | -0.17 | -0.2 | -0.21 | - | -0.18 | -0.2 | -0.23 | - | -0.17 | -0.21 | 2.67 | - | -0.27 | -0.41 | -0.37 | - | -0.3 | -0.24 | -0.26 | - | -0.53 | -0.53 | -0.54 | - | -0.38 | -0.57 | -3.48 | - | -0.59 | -0.55 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-34.82 | -27.57 | -48.37 | -33.36 | -41.79 | -39.10 | -37.48 | -27.78 | -33.55 | -30.91 | -28.96 | 66.19 | 28.54 | -3.32 | -47.37 | -135.24 | -159.47 | -145.58 | -112.54 | -86.34 | -95.35 | -105.00 | -119.69 | -133.95 | -113.84 | -91.66 | -70.61 | -77.67 | -79.87 | -80.39 | -79.04 | -45.47 | -30.13 | -18.40 | -7.47 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-24.31 | -19.67 | -35.99 | -27.42 | -34.68 | -32.93 | -32.05 | -23.91 | -29.41 | -27.65 | -26.67 | 61.38 | 39.75 | 23.61 | 1.15 | -77.72 | -98.70 | -97.65 | -84.10 | -74.79 | -80.87 | -87.50 | -98.49 | -109.09 | -94.27 | -77.53 | -61.83 | -72.44 | -74.45 | -74.90 | -73.60 | -42.27 | -28.01 | -17.10 | -6.94 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-74.54 | -69.08 | -58.80 | -36.99 | -46.00 | -43.14 | -39.74 | -28.27 | -34.20 | -31.12 | -28.64 | 67.00 | 29.40 | -2.27 | -48.38 | -137.15 | -161.09 | -147.44 | -113.42 | -63.04 | -96.99 | -107.00 | -122.02 | -102.60 | -113.88 | -91.20 | -69.49 | -64.67 | -76.47 | -76.99 | -75.65 | -22.79 | -22.79 | -10.99 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.9 | 4.0 | 2.5 | 2.6 | 5.3 | 5.3 | 6.4 | 6.8 | 7.2 | 7.0 | 7.3 | 13.2 | 20.6 | 19.3 | 14.5 | 2.4 | 2.4 | 2.4 | 2.4 | 7.5 | 7.5 | 7.5 | 7.5 | 5.4 | 5.4 | 5.4 | 5.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency